A Case of Cutaneous Vasculitis in the Setting of Systemic Lupus Erythematosus and Cocaine Use

Cocaine, one of most prevalent illicit substances in the United States, affects a multitude of organ systems and precedes numerous negative health outcomes. Many of the consequences of cocaine are linked to induction of vasoconstriction. For this reason, cocaine users are placed at considerable risk...

Full description

Bibliographic Details
Main Authors: Chad M. Jaenke BS, Sara R. Moore PhD, Matthew D. Miller BA, Anu Garg MD
Format: Article
Language:English
Published: SAGE Publishing 2023-05-01
Series:Journal of Investigative Medicine High Impact Case Reports
Online Access:https://doi.org/10.1177/23247096231176215
_version_ 1797823227004715008
author Chad M. Jaenke BS
Sara R. Moore PhD
Matthew D. Miller BA
Anu Garg MD
author_facet Chad M. Jaenke BS
Sara R. Moore PhD
Matthew D. Miller BA
Anu Garg MD
author_sort Chad M. Jaenke BS
collection DOAJ
description Cocaine, one of most prevalent illicit substances in the United States, affects a multitude of organ systems and precedes numerous negative health outcomes. Many of the consequences of cocaine are linked to induction of vasoconstriction. For this reason, cocaine users are placed at considerable risk of ischemic stroke, myocardial infarction, and cardiac arrhythmias. Furthermore, a prominent contaminant, levamisole, has been widely implicated in predisposing individuals to developing or exacerbating cutaneous vasculitides. This report details a 31-year-old woman with acute, localized necrotic skin lesions after cocaine use. Her clinical picture was complicated by a 17-year history of systemic lupus erythematosus (SLE) and Raynaud’s phenomenon. This case examines the challenge of forming a differential diagnosis, initiating an appropriate workup, and interpreting serologic-based and immunologic-based studies to differentiate between SLE and drug-based etiologies of skin necrosis. Finally, we discuss appropriate treatment plans to mitigate symptoms and reduce future instances of drug-induced vasculitis.
first_indexed 2024-03-13T10:20:54Z
format Article
id doaj.art-96e619aaf2e3496aa5301da74c8f6c45
institution Directory Open Access Journal
issn 2324-7096
language English
last_indexed 2024-03-13T10:20:54Z
publishDate 2023-05-01
publisher SAGE Publishing
record_format Article
series Journal of Investigative Medicine High Impact Case Reports
spelling doaj.art-96e619aaf2e3496aa5301da74c8f6c452023-05-20T20:33:45ZengSAGE PublishingJournal of Investigative Medicine High Impact Case Reports2324-70962023-05-011110.1177/23247096231176215A Case of Cutaneous Vasculitis in the Setting of Systemic Lupus Erythematosus and Cocaine UseChad M. Jaenke BS0Sara R. Moore PhD1Matthew D. Miller BA2Anu Garg MD3The University of Toledo Medical Center, OH, USAThe University of Toledo Medical Center, OH, USAThe University of Toledo Medical Center, OH, USAThe University of Toledo Medical Center, OH, USACocaine, one of most prevalent illicit substances in the United States, affects a multitude of organ systems and precedes numerous negative health outcomes. Many of the consequences of cocaine are linked to induction of vasoconstriction. For this reason, cocaine users are placed at considerable risk of ischemic stroke, myocardial infarction, and cardiac arrhythmias. Furthermore, a prominent contaminant, levamisole, has been widely implicated in predisposing individuals to developing or exacerbating cutaneous vasculitides. This report details a 31-year-old woman with acute, localized necrotic skin lesions after cocaine use. Her clinical picture was complicated by a 17-year history of systemic lupus erythematosus (SLE) and Raynaud’s phenomenon. This case examines the challenge of forming a differential diagnosis, initiating an appropriate workup, and interpreting serologic-based and immunologic-based studies to differentiate between SLE and drug-based etiologies of skin necrosis. Finally, we discuss appropriate treatment plans to mitigate symptoms and reduce future instances of drug-induced vasculitis.https://doi.org/10.1177/23247096231176215
spellingShingle Chad M. Jaenke BS
Sara R. Moore PhD
Matthew D. Miller BA
Anu Garg MD
A Case of Cutaneous Vasculitis in the Setting of Systemic Lupus Erythematosus and Cocaine Use
Journal of Investigative Medicine High Impact Case Reports
title A Case of Cutaneous Vasculitis in the Setting of Systemic Lupus Erythematosus and Cocaine Use
title_full A Case of Cutaneous Vasculitis in the Setting of Systemic Lupus Erythematosus and Cocaine Use
title_fullStr A Case of Cutaneous Vasculitis in the Setting of Systemic Lupus Erythematosus and Cocaine Use
title_full_unstemmed A Case of Cutaneous Vasculitis in the Setting of Systemic Lupus Erythematosus and Cocaine Use
title_short A Case of Cutaneous Vasculitis in the Setting of Systemic Lupus Erythematosus and Cocaine Use
title_sort case of cutaneous vasculitis in the setting of systemic lupus erythematosus and cocaine use
url https://doi.org/10.1177/23247096231176215
work_keys_str_mv AT chadmjaenkebs acaseofcutaneousvasculitisinthesettingofsystemiclupuserythematosusandcocaineuse
AT sararmoorephd acaseofcutaneousvasculitisinthesettingofsystemiclupuserythematosusandcocaineuse
AT matthewdmillerba acaseofcutaneousvasculitisinthesettingofsystemiclupuserythematosusandcocaineuse
AT anugargmd acaseofcutaneousvasculitisinthesettingofsystemiclupuserythematosusandcocaineuse
AT chadmjaenkebs caseofcutaneousvasculitisinthesettingofsystemiclupuserythematosusandcocaineuse
AT sararmoorephd caseofcutaneousvasculitisinthesettingofsystemiclupuserythematosusandcocaineuse
AT matthewdmillerba caseofcutaneousvasculitisinthesettingofsystemiclupuserythematosusandcocaineuse
AT anugargmd caseofcutaneousvasculitisinthesettingofsystemiclupuserythematosusandcocaineuse